Tactic Pharma LLC

Holdings History for Monopar Therapeutics - Common Stock, par value $0.001 per share (MNPR)

Symbol: MNPR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 0 shares
Security Ownership %: 0%

Tactic Pharma LLC ownership in Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR)

30 Jan 2026 - Tactic Pharma LLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of Monopar Therapeutics Common Stock, par value $0.001 per share (MNPR). This represents 0% ownership of the company. In their previous filing dated 24 Sep 2025, Tactic Pharma LLC had reported owning 506,199 shares, indicating a decrease of +100%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Tactic Pharma LLC	0%	-94%	$0	0	-506,199	-100%	$65.29	13D/A	28 Jan 2026	30 Jan 2026, 14:32
Robinson Chandler	7.5%		$18,253,536	506,199			$36.06	13D/A	24 Sep 2025	24 Sep 2025, 20:59